Four Decades for Justice
February 10, 2016
Cravath represented the underwriter, Barclays, in connection with the US$1.06 billion registered secondary common stock offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The shares were listed on the New York Stock Exchange. The transaction closed on February 10, 2016.
The Cravath team included partners William J. Whelan III and William V. Fogg and associates Jacob B. Ornstein and Martin P. Pepeljugoski. Alan Campbell also worked on this matter.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.